ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/2/2025ACC: 0001415889-25-009633
Officer· Interim CFO
Since Jun 2021
-8.40K
Net shares
Net seller
$13.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.40K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.40K
Price / share
$1.58
Trade value
$13.27K
% of position
6.6%
3/31/2025
126.89K→118.49K
Total
Net shares
−8.40K
Net value
-$13.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2025 | F · Tax Withholding | −8.40K | $1.58 | $13.27K | 6.6% | 126.89K | 118.49K |
| Total | −8.40K | -$13.27K | ||||||
Derivative Transactions0
No derivative transactions reported